• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Laurus Labs Ltd.
    25 Jul 2025
    894.85
    -0.02%
    Laurus Labs Q1 FY26 net profit up at 163 cr
    Business Line
    The revenue of the Hyderabad-based company increased31% at 1570 crore against 1195 crore in theyear-ago period
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. has gained 34.24% in the last 3 Months
    logo
    Indoco Remedies Ltd.
    25 Jul 2025
    304.70
    3.80%
    'Sell' Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside Here's Why
    'Sell' Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside Here's Why
    NDTV Profit
    Dolat Capital maintains Sell' rating on Indoco Remedies and revises target price
    Copy LinkShare onShare on Share on Share on
    Indoco Remedies Ltd. is trading at high day volume of 1.2M.
    logo
    Sun Pharmaceutical Industries Ltd.
    25 Jul 2025
    1610.50
    0.53%
    Sun Pharma settles US antitrust litigation for $200 million
    Business Line
    The settlement amounts may be reduced if more than a certain percentage of the total insured class members opt out of the putative class, says the company
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading below its 50 day SMA of 1641.1
    Sun Pharma Shares Decline On $200 Million US Antitrust Litigation Payout
    NDTV Profit | 25 Jul 2025 2 more
    Sun Pharma Settles US Antitrust Litigation For $200 Million
    NDTV Profit | 25 Jul 2025
    Sun Pharma resolves US antitrust case with $200 mn agreement
    Business Standard | 25 Jul 2025
    logo
    Torrent Pharmaceuticals Ltd.
    25 Jul 2025
    3535.50
    0.11%
    Torrent Pharma Share Price Gets Investec 'Buy' Call JB Chemicals Acquisition to Boost Growth
    Torrent Pharma Share Price Gets Investec 'Buy' Call JB Chemicals Acquisition to Boost Growth
    NDTV Profit
    Once the deal is finalised, Torrent Pharmaceuticals will become India's second most valued pharma company.
    Copy LinkShare onShare on Share on Share on
    Torrent Pharmaceutic.. has an average target of 3746.00 from 5 brokers.
    logo
    Syngene International Ltd.
    25 Jul 2025
    657.25
    -2.02%
    Syngene International CEO Confident Of Maintaining Mid-Teens Revenue Growth In FY26 After Strong Q1 Results
    Syngene International CEO Confident Of Maintaining Mid-Teens Revenue Growth In FY26 After Strong Q1 Results
    NDTV Profit
    Syngene International has made a robust start to the financial year 2025-26, with a strong growth in revenue from operations and the net profit in the first quarter.
    Copy LinkShare onShare on Share on Share on
    Syngene International Ltd. is trading below its 30 day SMA of 659.0
    Pilot wins, biologics ramp-up drive Syngene's Q1; PAT growth to moderate, says Peter Bains
    Business Line | 24 Jul 2025
    logo
    Dr. Reddy's Laboratories Ltd.
    24 Jul 2025
    US FDA Observation
    1310.40
    0.74%
    Q1 miss for Dr Reddy's, but analysts remain hopeful for future prospects
    Business Standard
    Despite missing Q1 expectations, Dr Reddy's continues to see growth in key markets like Europe and India, while managing costs to offset challenges in the US
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    logo
    Lupin Ltd.
    24 Jul 2025
    2051.80
    0.28%
    Lupin gets USFDA nod for generic diabetes drugs
    Business Line
    The company received approval from the USFDA for its abbreviated new drug applications for Liraglutide Injection single-patient-use prefilled pens and glucagon for injection vials, the drug maker said in a statement
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
    logo
    Senores Pharmaceuticals Ltd.
    24 Jul 2025
    Insider Trades
    686.50
    0.39%
    Senores Pharma hits all time high on posting Q1 results; PAT up 95% YoY
    Business Standard
    Senores Pharmaceuticals shares touched an all-time high in trade, gaining 15.6 per cent in trade on BSE after posting Q1 results
    Copy LinkShare onShare on Share on Share on
    Senores Pharmaceuticals Ltd. is trading above its 150 day SMA of 586.0
    logo
    Dr. Reddy's Laboratories Ltd.
    24 Jul 2025
    US FDA Observation
    1310.40
    0.74%
    Dr. Reddy's Shares Spike After Morgan Stanley, BofA Raises Price Target Post Q1 Results
    Dr. Reddy's Shares Spike After Morgan Stanley, BofA Raises Price Target Post Q1 Results
    NDTV Profit
    The company posted a consolidated net profit of Rs 1,418 crore for the AprilJune period, up just 1.8% year-on-year and below the Rs 1,514 crore consensus estimate.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laborato.. has an average target of 1278.56 from 9 brokers.
    Dr. Reddy's Q1 Results Review: Systematix Maintains 'Hold' Rating On Weak U.S. Performance
    NDTV Profit | 24 Jul 2025 9 more
    Dr Reddy's Laboratories Q1 print misses target; brokerages split on outlook
    Business Standard | 24 Jul 2025
    Dr. Reddy's Q1 Review: Brokerage Split On Margin Recovery What's The Takeaway?
    NDTV Profit | 24 Jul 2025
    Dr Reddy's Q1 result: Net profit up 2%, revenue hits record 8,545 crore
    Business Standard | 23 Jul 2025
    At 1,409 crore, Dr Reddy's Q1 FY26 net profit up 1%
    Business Line | 23 Jul 2025
    Dr Reddy's Q1 profit up 1% to 1,410 crore, revenue rises to 8,545 cr
    Business Standard | 23 Jul 2025
    Dr Reddy's Laboratories Q1 Results: Profit Up 1.8%, Misses Estimates
    NDTV Profit | 23 Jul 2025
    Dr Reddy's reports 1% rise in Q1 profit to 1,409 cr; revenue up 11%
    Business Line | 23 Jul 2025
    Dr Reddy's Q1 FY26: Double digit growth in topline, pressure on margins likely
    Business Line | 23 Jul 2025
    Dr Reddy's Q1 Results Preview: Analysts Outlook Mixed, See Double-Digit Growth
    NDTV Profit | 22 Jul 2025
    logo
    Natco Pharma Ltd.
    24 Jul 2025
    852.15
    0.09%
    Natco Pharma to acquire 35.75% stake in South Africa's Adcock Ingram for 1,970 cr
    Business Line
    Natco said the strategic investment aims to expand its geographic presence in South Africa, marking a significant global step for the Indian pharmaceutical company.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 385 to 317 in Jun 2025 qtr
    Natco Pharma to acquire 35.75% stake in Adcock Ingram for 2,000 cr
    Business Standard | 23 Jul 2025
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • L T Elevator
    • TechD Cybersecurity
    • Euro Pratik Sales
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd